Online Only Articles

Clonal hematopoiesis in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis

Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Tumor Immunology, Berlin
Experimental and Clinical Research Center, Charité, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin;Charité – Universitätsmedizin Berlin, Department of Nephrology and Intensive Care Medicine, Berlin
Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Tumor Immunology, Berlin
Experimental and Clinical Research Center, Charité, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin
Experimental and Clinical Research Center, Charité, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin
Experimental and Clinical Research Center, Charité, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin;Charité – Universitätsmedizin Berlin, Department of Nephrology and Intensive Care Medicine, Berlin
Charité – Universitätsmedizin Berlin, Department of Nephrology and Intensive Care Medicine, Berlin
Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Tumor Immunology, Berlin
Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Tumor Immunology, Berlin
Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Tumor Immunology, Berlin
Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Tumor Immunology, Berlin;German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg
HELIOS Klinikum Berlin-Buch, Department of Cardiology and Nephrology, Berlin, Germany
Experimental and Clinical Research Center, Charité, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin;Charité – Universitätsmedizin Berlin, Department of Nephrology and Intensive Care Medicine, Berlin
Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Tumor Immunology, Berlin;German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg
Vol. 105 No. 6 (2020): June, 2020 https://doi.org/10.3324/haematol.2019.223305